Site controlled transgenic mice validating increased expression from human matrix metalloproteinase (MMP-1) promoter due to a naturally occurring SNP

Matrix Biology

Volumn 28, Issue 7, 2009, Pages 425-431

  Coon, Charles I ^a   Fiering, Steven ^a   Gaudet, Justin ^a   Wyatt, Colby A ^a   Brinckerhoff, Constance E ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

galactosidase; Fibroblasts; Gene expression; mRNA; Single nucleotide polymorphism

Indexed keywords

BETA GALACTOSIDASE; GUANINE; INTERSTITIAL COLLAGENASE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LOCUS; GENOME SIZE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; CYTOKINES; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MICE; MICE, TRANSGENIC; NIH 3T3 CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

MURINAE; MUS; MUS MUSCULUS;

EID: 70350397259     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2009.06.003     Document Type: Article

References (37)

1. Astolfi C.M., Shinohara A.L., da Silva R.A., Santos M.C., Line S.R., and de Souza A.P. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J. Clin. Periodontol. 33 (2006) 699-703
2. Balbin M., Fueyo A., Knauper V., Lopez J.M., Alvarez J., Lanchez L.M., Quesada V., Bordallo J., Murphy G., and Lopez-Otin C. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem. 276 (2001) 10253-10262
3. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 3 (2002) 207-214
4. Bronson S.K., Plaehn E.G., Kluckman K.D., Hagman J.R., Maeda N., and Smithies O. Single-copy transgenic mice with chosen-site integration. Proc. Natl. Acad. Sci. USA 93 (1996) 9067-9072
5. Burrage P.S., and Brinckerhoff C.E. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr. Drug Targets 8 (2007) 293-303
6. Burrage P.S., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11 (2006) 529-543
7. Burrage P.S., Huntington J.T., Sporn M.B., and Brinckerhoff C.E. Regulation of matrix metalloproteinase gene expression by an RXR-specific ligand. Arthritis Rheum. 56 (2007) 892-904
8. Burrage P.S., Schmucker A.C., Ren Y., Sporn M.B., and Brinckerhoff C.E. Retinoid X receptor and peroxisome proliferators-activated receptor gamma agonists cooperate to inhibit matrix metalloproteinase gene expression. Arthritis Res. Ther. 10 (2008) R139
9. D'Armiento J., Dalal S.S., Okada Y., Berg R.A., and Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71 (1992) 955-961
10. D'Armiento J.M., DiColandrea T., Dalal S.S., Okada Y., Huang M.T., Conney A.H., and Chada K. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increase susceptibility to tumorigenesis. Mol. Cell. Biol. 15 (1995) 5732-5739
11. Evans V., Hatzolpoulos A., Aird W.C., Rayburn H.B., and Kuivenhoven J.A. Targeting the HPRT locus in mice reveals differential regulation of Tie2 gene expression in the endothelium. Physiol. Genomics 2 (2000) 67-75
12. Fahmi H., Di Battista J.A., Pelletier J.P., Mineau F., Ranger P., and Martel-Pelletier J. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 44 (2001) 595-607
13. Guillot P.V., Liu L., Kuivenhoven J.A., Guan J., Rosenberg R.D., and Aird W.C. Targeting of human eNOS promoter to the HPRT locus of mice leads to tissue-restricted transgene expression. Physiol. Genomics 2 (2000) 77-83
14. Hughes S., Agbaje O., Bowen R.L., Holliday D.L., Shaw J.A., Duffy S., and Jones J.L. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin. Cancer Res. 13 (2007) 6673-6680
15. Kanamori Y., Matsushima M., Minaguchi T., Kobayashi K., Sagae S., Kudo R., Terakawa N., and Nakamura Y. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 59 (1999) 4225-4227
16. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
17. Li J., Ghio A.J., Cho S.-H., Brinckerhoff C.E., Sidney A., Simon S.A., and Liedtke W. Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a β-arrestin-dependent manner via activation of RAS. Environ. Health Perspect. 117 (2009) 400-409
18. Magness S.T., Tugores A., and Brenner D.A. Analysis of ferrochelatase expression during hematopoietic development of embryonic stem cells. Blood 95 (2000) 3568-3577
19. Mengshol J.A., Vincenti M.P., and Brinckerhoff C.E. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation of p38 MAPK and JNK pathways. Nucleic Acids Res. 29 (2001) 4361-4372
20. Mercer B.A., Wallace A.M., Brinckerhoff C.E., and D'Armiento J.M. Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am. J. Respir. Cell Mol. Biol. 40 (2009) 4-12
21. Misra R.P., Bronson S.K., Xiao Q., Garrison W., Jixuan L., Zhao R., and Duncan S.A. Generation of single-copy transgenic mouse embryos directly from ES cells by tetraploid embryo complementation. BMC Biotechnol. 1 (2001) 12-20
22. Nagy A., Gertsenstein M., Vinstersten K., and Behringer R. Manipulating the Mouse Embryo. 3rd edition (2003), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
23. Nishioka Y., Kobayashi K., Sagae S., Ishioka S., Nishikawa A., Matsushima M., Kanamori Y., Minaguchi T., Nakamura Y., Tokino T., and Kudo R. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn. J. Cancer Res. 90 (2000) 612-615
24. Nishioka Y., Sagai S., Nishikawa A., Ishioka S., and Kudo R. A relationship between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett. 200 (2003) 49-55
25. Ornskov D., Nexo E., and Sorensen B.S. Real-time PCR is a sensitive and precise method for quantifying transcription from reporter plasmids. Scand. J. Lab. Invest. 64 (2004) 723-728
26. Pearce E., Tregouet D.A., Samnegård A., Morgan A.R., Cox C., Hamsten A., Eriksson P., and Ye S. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ. Res. 97 (2005) 1070-1076
27. Pirhan D., Atilla G., Emingil G., Sorsa T., Tervahartiala T., and Berdeli A. Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis. J. Clin. Periodontol. 35 (2008) 862-870
28. Raymond L., Eck S., Mollmark J., Hays E., Tomek I., Kantor S., Elliott S., and Vincenti M. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J. Cell. Physiol. 207 (2006) 683-688
29. Reid L.H., Sheseley E.G., Kim H.S., and Smithies O. Cotransformation and gene targeting in mouse embryonic stem cells Mol. Cell Biol. 11 (1991) 2769-2777
30. Rutter J.L., Mitchell T.I., Buttice G., Meyers J., Gusella J.F., Ozelius L.J., and Brinckerhoff C.E. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58 (1998) 5321-5325
31. Suemori H., and Katsuji N. Establishment of the embryo-derived stem (ES) cell lines from mouse blastocysts: effect of the feeder layer. Dev. Growth Differ. 29 (1987) 133-139
32. Vivian J.L., Klein W.H., and Hasty P. Temporal, spatial and tissue-specific expression of a myogenin-lacZ transgene targeted to the HPRT locus in mice. Biotechniques 27 (1999) 154-162
33. Wyatt C.A., Coon C.I., Gibson J.J., and Brinckerhoff C.E. Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase-1 to enhance gene expression in normal stromal cells. Cancer Res. 62 (2002) 7200-7202
34. Wyatt C.A., Geoghegan J.C., and Brinckerhoff C.E. Short hairpin RNA mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res. 65 (2005) 11101-11108
35. Yang B., Williamson R.A., and Sigmund C.D. Appropriate tissue- and cell-type expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination. J. Biol. Chem. 275 (2000) 1073-1078
36. Ye S., Dhillon S., Turner S.J., Bateman A.C., Theaker J.M., Pickering R.M., Day I., and Howell W.M. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 61 (2001) 1296-1298
37. Ye S., Gale C.R., and Martyn C.N. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur. Heart J. 24 (2003) 1668-1671